SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-21-060092
Filing Date
2021-11-16
Accepted
2021-11-16 17:05:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea150419-f3_altamiratherap.htm F-3 328941
2 OPINION OF CONYERS DILL & PEARMAN LIMITED ea150419ex5-1_altamira.htm EX-5.1 33086
3 OPINION OF LOWENSTEIN SANDLER LLP ea150419ex5-2_altamira.htm EX-5.2 24710
4 CONSENT OF DELOITTE AG ea150419ex23-1_altamira.htm EX-23.1 3432
5 GRAPHIC ex5-1_001.jpg GRAPHIC 6200
  Complete submission text file 0001213900-21-060092.txt   400163
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-261127 | Film No.: 211417158
SIC: 2834 Pharmaceutical Preparations